The invention encompasses a novel class of diaryl ether derivatives which inhibit the processing of APP by the putative γ-secretase while sparing Notch signaling pathway, and thus are useful in the treatment or prevention of Alzheimer's disease without the development of Notch inhibition mediated gastrointestinal issues. Pharmaceutical compositions and methods of use are also included.
该发明涵盖了一种新型的
二苯醚衍
生物类,这种类可以抑制APP的加工,同时保留Notch信号通路,因此可以用于治疗或预防阿尔茨海默病,而不会引起Notch抑制介导的胃肠问题。此外,还包括药物组合物和使用方法。